13F

Stock

Iovance Biotherapeutics, Inc.

IOVA · held by 3 managers

Reported value

$6.26M

Holders

3

+1 new · −0 exited

Holders’ est. mark

$433.3K

Price effect on 2 books still in the name

Largest holder

$5.68M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC604.6K$5.68M$378.5KAdded$3.46M
Leonteq Securities AG40K$375.6K$54.8KAdded$54.8K
Henshaw Capital LLC22.1K$207.9KNew

Positions as of Q3 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.